Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3373-3389.e16
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
Mi Young Lim, Seungpyo Hong, Young‐Do Nam
Frontiers in Immunology (2025) Vol. 15
Open Access
Crosstalk between gut microbiota and cancer immunotherapy: present investigations and future perspective
Yuhui Tang, Qiaoting Cai, Zhi Tian, et al.
Research (2025) Vol. 8
Open Access
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
What Is the Role of Fecal Microbiota Transplantation in Immunotherapy Trials? Current Perspectives and Future Directions
Edmond Rafie, Miguel Zugman, Sumanta K. Pal, et al.
European Urology Focus (2025)
Closed Access
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access
Skin microbiome and dermatologic disorders
Tiffany C. Scharschmidt, Julia A. Segre
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access
Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 5
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
Julie Rodriguez, Zahra Hassani, Carolina Alves Costa Silva, et al.
The Lancet Microbe (2024), pp. 100948-100948
Open Access | Times Cited: 3
International consensus statement on microbiome testing in clinical practice
Serena Porcari, Benjamin H. Mullish, Francesco Asnicar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 2, pp. 154-167
Closed Access | Times Cited: 3
The gut-brain axis in depression: Are multi-omics showing the way?
Jane A. Foster, Madhukar H. Trivedi
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101741-101741
Open Access | Times Cited: 2
Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial
Marius Bredon, Karine le Malicot, Christophe Louvet, et al.
Gastroenterology (2024)
Open Access | Times Cited: 1
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 1
Akkermansia in the gastrointestinal tract as a modifier of human health
María E. Panzetta, Raphael H. Valdivia
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Intestinal microbiome and myelodysplastic syndromes: current state of knowledge and perspectives for future
Marin Simunic, Kathy L. McGraw, Steven Z. Pavletic, et al.
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 1
Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy
Lijun Ning, Jie Hong
Cell (2024) Vol. 187, Iss. 13, pp. 3231-3232
Closed Access
Gut microbiome discovery provides roadmap for life-saving cancer therapies
Giorgia Guglielmi
Nature (2024)
Closed Access
Towards enhancing the predictive value of the microbiota for cancer immunotherapy
Amiran Dzutsev, Romina S. Goldszmid
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 771-773
Closed Access
Emergent metabolic interactions in resistance toClostridioides difficileinvasion
Achuthan Ambat, Naomi Iris van den Berg, Francisco Zorrilla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nichtkleinzelliges Lungenkarzinom: Chancen der Immuntherapie aus Mikrobiom errechnen
Rüdiger Meyer
Deutsches Ärzteblatt (2024)
Closed Access
Relationship between energetic gap and sensitivity to anti- programmed cell death 1 immune checkpoint inhibitors in non-small cell lung cancer patients: The ELY-2 Study.
Manuela Tiako Meyo, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, et al.
Clinical Nutrition ESPEN (2024) Vol. 64, pp. 44-50
Closed Access
Impact of the Lung Microbiota on Development and Progression of Lung Cancer
Amine Belaïd, Barnabé Roméo, Guylène Rignol, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3342-3342
Open Access
The methionine cycle and its cancer implications
Valentina Tassinari, Jia Wang, Wen‐Lian Chen, et al.
Oncogene (2024) Vol. 43, Iss. 48, pp. 3483-3488
Closed Access
Redefining the Gastric Microbes in Promoting Gastric Tumorigenesis: The Rise of the Non–H. pylori Microbiome
Chi Chun Wong, Jun Yu
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2051-2054
Closed Access
Longitudinal Fecal Microbiota Profiles in A Cohort of Non-Hospitalized Adolescents and Young Adults with COVID-19: Associations with SARS-CoV-2 Status and Long-Term Fatigue
Christine Olbjørn, Milada Hagen, Aina Elisabeth Fossum Moen, et al.
Pathogens (2024) Vol. 13, Iss. 11, pp. 953-953
Open Access
Page 1 - Next Page

Scroll to top